Multiple Chemical Sensitivity (MCS)

When everyday chemicals seem to trigger symptoms

Last reviewed: October 2026 · 30 sources

Educational only, not medical advice. This page shares general information and community experience. It isn’t a diagnosis or a treatment plan. Please talk with your doctor or another licensed healthcare provider before starting, stopping, or changing any test, supplement, medication, or treatment.

At a glance

  • What it is: a chronic condition in which people report symptoms in several body systems after low-level exposure to everyday chemicals such as fragrances, cleaning products and fumes [1, 2].
  • Names: multiple chemical sensitivity (MCS), idiopathic environmental intolerance (IEI) and “chemical intolerance” are all used [3, 4, 5].
  • How common: in a 2016 U.S. survey, 12.8% of adults said they had been medically diagnosed with MCS and 25.9% reported chemical sensitivity [6].
  • Diagnosis: there’s no validated diagnostic test. Questionnaires such as the QEESI are used for screening and research, alongside a check for other causes [3, 7, 8].
  • Debate: the cause is unknown. Researchers disagree about how much is driven by chemicals themselves and how much by the nervous system, learning and expectations [8, 9].

Many people find that perfume, air fresheners, cleaning products or fresh paint leave them with headaches, breathing trouble or brain fog. For some, the reactions are frequent and severe enough to limit work and daily life [6]. Your symptoms are real, whatever their cause. This guide explains what’s known, what’s debated and what you can do.

What MCS is

A 1999 consensus of researchers and clinicians defined MCS as a chronic condition with symptoms that recur reproducibly in response to low levels of exposure to multiple unrelated chemicals, affect multiple organ systems, and improve or resolve when the triggers are removed [1].

Names. In 1996, a workshop organized by the World Health Organization’s International Programme on Chemical Safety recommended the name idiopathic environmental intolerance (IEI). It said the term MCS “makes an unsupported judgment on causation” [3]. “Idiopathic” means the cause is unknown. Some researchers now use IEI instead of MCS [4].

TILT. Dr. Claudia Miller proposed “toxicant-induced loss of tolerance” (TILT): an initial exposure causes susceptible people to lose tolerance, and afterward tiny amounts of previously tolerated chemicals, foods or drugs trigger symptoms. She calls it a “yet-to-be-proven” theory of disease [10]. Her group uses the broader term “chemical intolerance” [5].

Common reported symptoms and triggers

The Job Accommodation Network (JAN) lists symptoms that may include [2]:

  • Headaches, dizziness, fatigue and nausea
  • Breathing difficulties and tightening of the throat
  • Difficulty concentrating and memory problems
  • Eczema, muscle pain and arthritis-like sensations

In the 2016 U.S. survey, 86.2% of people with diagnosed MCS said fragranced consumer products caused health problems such as migraines; 71.0% also had asthma [6]. Commonly reported triggers include fragrances, cleaning agents, tobacco smoke, pesticides, molds, vehicle exhaust, paint, new carpet and solvents [2]. Fragranced products such as cleaning supplies, air fresheners and personal care products are commonly reported triggers [11].

How MCS is assessed

No validated test. The AAAAI notes that no single test or combination of tests has been validated as diagnostic, and that immune tests have not been confirmed to diagnose chemically triggered symptoms [3].

Questionnaires. The Quick Environmental Exposure and Sensitivity Inventory (QEESI), developed by Miller and Prihoda, is used in more than 10 countries [7]. Its developers’ group describes it as a validated questionnaire and has created a three-question screen, the BREESI [5]. These tools measure how much chemical intolerance someone reports. They don’t show what causes it.

Ruling out other causes. The American College of Occupational and Environmental Medicine (ACOEM) recommends a medical evaluation suited to your symptoms, treating any diagnosable condition, and avoiding unproven tests that may add to distress [8]. The 1999 consensus excludes cases fully explained by another disorder such as mastocytosis [1]. See our MCAS guide.

Living with it: practical exposure reduction

These steps make sense whatever the cause, but they haven’t been tested in controlled trials for MCS.

  • Remove sources first. The EPA says the most effective way to improve indoor air is usually to remove sources of pollution or reduce their emissions [12]. Air fresheners, cleaning products and other household products release VOCs (volatile organic compounds) [13]. Evidence: general indoor-air guidance.
  • Choose fragrance-free and low-VOC products. ISEAI suggests fragrance-free cleaning and low-VOC products [14]. In a small program of home visits, three case studies reported fewer symptoms as fragrance levels in indoor air dropped [11]. Evidence: case studies.
  • Ventilate and filter. The EPA advises ventilation and says air cleaners are a supplement to source control. Most air cleaners are not designed to remove gases [12, 15]. Evidence: general indoor-air guidance.
  • Ask for accommodations at work. JAN explains that the ADA has no list of qualifying conditions; whether MCS counts as a disability depends on how much it limits major life activities [2]. JAN’s suggestions include fragrance-free policies, better ventilation, advance notice of painting or pesticide use, and alternative workspaces or working from home [2]. In the U.S. survey, 60.7% of people with MCS had lost workdays or a job because of fragranced products at work [6]. Evidence: practical guidance.
  • Plan for medical visits. An Italian expert consensus suggests fragrance-free, ventilated rooms for hospital patients with MCS [16]. In the U.S. survey, 82.1% of people with MCS said they would prefer fragrance-free health care facilities [6]. Evidence: expert consensus.

How MCS overlaps with the other conditions

  • Mold toxicity. A Finnish group reported high rates of chemical sensitivity among occupants of a water-damaged police station [17]. A 2023 German guideline found no evidence linking indoor mold to MCS [18]. JAN lists molds among triggers [2].
  • MCAS. Miller’s group proposes that fragrances and other chemicals sensitize mast cells [11]. A 2025 Canadian review lists chemical sensitivity among conditions “not suggestive of MCAS” [19].
  • CIRS. ISEAI groups CIRS, MCAS and MCS as “environmentally acquired illness,” and writes that a person with biotoxin illness “is likely to become more sensitive to chemicals” [20]. We didn’t find studies comparing CIRS and MCS directly.
  • POTS. ISEAI lists dysautonomias such as POTS among illnesses it thinks may be “caused or exacerbated” by environmental toxins [20]. We didn’t find research linking MCS and POTS.

What’s known and what’s debated

Generally accepted: many people report symptoms after low-level chemical exposures, and these symptoms can disrupt work and daily life [6]. There’s no validated diagnostic test [3].

How common it is. Surveys give very different numbers depending on the definition. U.S. state surveys in the 1990s found 2–6% with a diagnosis of MCS [1], while the 2016 national survey found 12.8%; that survey relied on self-report [6].

Provocation studies. A systematic review of 37 challenge studies found that people with MCS did react to chemical exposures, but mainly when they could tell active substances from sham ones. The authors suggest expectations and prior beliefs may play a role [9]. Miller’s group notes that challenge studies have not confirmed fragrance sensitivity and proposes a mast cell explanation instead [11].

Mind and body. Some researchers see a role for learned responses and anxiety-like thinking patterns, alongside biology [4]. ACOEM notes that modern medicine “no longer supports a mind-body dichotomy” [8]. A nocebo or learned response doesn’t mean symptoms are imagined or faked.

Mainstream positions. ACOEM says evidence does not exist to define MCS as a distinct disease, and both ACOEM and the AAAAI use the term IEI [8, 3]. Others, including the 1999 consensus authors, argue it should be formally diagnosed [1]. You may hear both views from different doctors.

Functional & integrative perspective · evidence varies

The functional and integrative perspective

How functional and integrative practitioners see MCS

These are practitioners’ own models, described in their terms. ACOEM says evidence does not exist to define MCS as a distinct disease [8], so read each one as a hypothesis.

  • Loss of tolerance (“TILT”). Miller proposes that an exposure causes susceptible people to lose tolerance, after which tiny amounts of everyday chemicals trigger symptoms [10]. Her group proposes that fragrances and other chemicals trigger mast cells along the smell and limbic pathways, causing “brain fog” [11]. Evidence: a theory and three case studies.
  • “Environmentally acquired illness.” ISEAI groups chemical sensitivity with mold illness, MCAS and persistent infections, says exposures “may be cumulative,” and says treatment often involves reducing exposure and what it calls “detoxification” [20]. Evidence: a professional society’s position based on clinical experience.
  • The “cell danger response.” Dr. Robert Naviaux proposes that chronic disease can follow when cells’ protective response to threats doesn’t switch off, and lists chemical sensitivity syndromes among his examples [21]. Evidence: a theoretical model; not tested in MCS.
  • A sensitized nervous system. Dr. Neil Nathan writes that he first recommended limbic retraining mainly for patients with MCS [22]. Evidence: clinical observation.

What functional and integrative practitioners often recommend

Functional, integrative and environmental-medicine clinicians often use the approaches below. Evidence varies, and most have not been tested in controlled trials. This is not medical advice. Please talk with a licensed clinician before trying any of them.

  • Lowering exposure. Miller’s group uses structured home visits to find and reduce exposures [11]; see practical exposure reduction above. The AAAAI cautions that some avoidance programs become extreme, and that there is evidence such programs may make patients worse [3]. Evidence: general indoor-air guidance and case studies.
  • Nervous-system (“limbic”) retraining. Nathan has recommended the Dynamic Neural Retraining System (DNRS) to 150–200 patients [22]. One small trial of a similar program in fibromyalgia and chronic fatigue reported improvements, but fewer than half of participants finished it [23]. Evidence: we found no controlled trials in MCS.
  • “Detox” approaches. The AAAAI describes sweating and oral minerals and oils as an undocumented form of “detoxification” [3], and the NIH’s complementary-health center calls studies of “detox” programs few and low quality [24]. Evidence: no controlled trials in MCS found.
  • “Neutralization.” Some practitioners give chemical or food extracts by injection or under the tongue. The AAAAI says no controlled clinical trial has evaluated this [3]. Evidence: untested.
  • A biopsychosocial approach. Some clinicians recommend gradually increasing activity and cognitive behavioral therapy [25]. ACOEM recommends building a working partnership with patients aimed at restoring function [8]. Evidence: AAAAI cites one study with short-term benefit from inpatient psychotherapy and no long-term studies [3].

See also the MCAS and mold toxicity perspectives.

Want to know who’s behind this site? Read our story.

What to do next

General information, not a diagnosis or a treatment plan. A licensed clinician can tell you which of these steps fit you.

  1. Step 1Start this week

    • Note what you were exposed to when symptoms started, such as air fresheners, cleaning products and other household products, which release VOCs [13].
    • AHRQ suggests writing down all your questions and concerns before a visit [29].
    • Our symptom checklist can help you organize what you notice.

  2. Step 2Choose who to see

    • Start with your primary care doctor: AHRQ calls your doctor “the first person to ask” [29].
    • ACOEM recommends a medical evaluation suited to your symptoms and treatment of any diagnosable condition [8].
    • For occupational and environmental medicine, the AOEC directory lists clinics in the U.S. and Canada [30]. For work questions, JAN explains workplace accommodations [2].
    • See also the provider directories on our homepage.

  3. Step 3Tests to ask about

    • There’s no validated diagnostic test for MCS [3].
    • Ask what other conditions should be checked [8]. The 1999 consensus excludes cases fully explained by another disorder such as mastocytosis [1].
    • Questionnaires such as the QEESI are used for screening and research [3, 7, 8]. ACOEM advises avoiding unproven tests [8].

  4. Step 4Everyday steps mainstream sources support

    • Remove sources first: the EPA says this is usually the most effective way to improve indoor air [12].
    • Choose fragrance-free and low-VOC products [14], and ventilate; air cleaners add to, but don’t replace, source control [12, 15].
    • At work, JAN lists fragrance-free policies and better ventilation among possible accommodations [2]. Evidence: general guidance, not trials in MCS.

  5. Step 5Prepare for the appointment

    • Bring a list of all the medicines you take [29]. Our Doctor visit prep sheet has space for your exposures and past results.
    • If you feel dismissed, consider a second opinion: AHRQ says wanting one “is not pushy or rude” and suggests asking for a doctor who doesn’t work in the same office [29].
    • Ask that your records note your need for fragrance-free care; an Italian expert consensus suggests fragrance-free, ventilated rooms for hospital patients with MCS [16]. The EPA’s indoor air guide is a reliable starting point at home [12].
    • Then use the Questions to ask your doctor below.

  6. Step 6When to get urgent care

    • Call 911 for severe shortness of breath at rest, bluish lips or face, or severe chest pain [26], or signs of anaphylaxis such as trouble breathing or throat swelling [27]. If you’re having thoughts of suicide, call or text 988 [28].
    • See the full list under When to get urgent help.

Questions to ask your doctor

  • Could asthma, allergies or a mast cell disorder explain my reactions?
  • What other conditions should we check for?
  • Would a questionnaire like the QEESI help us track my symptoms?
  • Can you note my need for fragrance-free care in my records?
  • Would a referral to an allergist, occupational medicine doctor or psychologist help?
  • How can I document my needs for workplace accommodations?

When to get urgent help

Call 911 or your local emergency number if you have severe shortness of breath at rest, bluish lips or face, severe chest pain, or drowsiness or confusion with breathing trouble [26]. Signs of a severe allergic reaction (anaphylaxis), such as trouble breathing, throat or face swelling, or fainting, also need emergency care; use epinephrine if your clinician has prescribed it [27]. If you are having thoughts of suicide, call or text 988 [28].

Sources

Numbers in brackets in the text link to these sources. Links were checked in October 2026. Some sources are written by people who support a particular approach; we've tried to say so in the text.

  1. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health. 1999;54(3):147-149. PMID: 10444033. https://doi.org/10.1080/00039899909602251
  2. Job Accommodation Network (JAN). Multiple Chemical Sensitivity. Web page, accessed October 14, 2026. https://askjan.org/disabilities/Multiple-Chemical-Sensitivity.cfm
  3. American Academy of Allergy, Asthma and Immunology (AAAAI) Board of Directors. Idiopathic environmental intolerances (position statement). J Allergy Clin Immunol. 1999;103(1 Pt 1):36-40. PMID: 9893182. https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Idiopathic-environmental-intolerances-1999.pdf
  4. Hausteiner C, Bornschein S, Zilker T, Henningsen P, Förstl H. Dysfunctional cognitions in idiopathic environmental intolerances (IEI)—an integrative psychiatric perspective. Toxicol Lett. 2007;171(1-2):1-9. PMID: 17548174. https://doi.org/10.1016/j.toxlet.2007.04.010
  5. Palmer RF, Jaén CR, Perales RB, et al. Three questions for identifying chemically intolerant individuals in clinical and epidemiological populations: the Brief Environmental Exposure and Sensitivity Inventory (BREESI). PLoS One. 2020;15(9):e0238296. PMID: 32936802. https://pmc.ncbi.nlm.nih.gov/articles/PMC7494077/
  6. Steinemann A. National prevalence and effects of multiple chemical sensitivities. J Occup Environ Med. 2018;60(3):e152-e156. PMID: 29329146. https://pmc.ncbi.nlm.nih.gov/articles/PMC5865484/
  7. Hojo S, Mizukoshi A, Azuma K, et al. New criteria for multiple chemical sensitivity based on the Quick Environmental Exposure and Sensitivity Inventory developed in response to rapid changes in ongoing chemical exposures among Japanese. PLoS One. 2019;14(4):e0215144. PMID: 31026284. https://pmc.ncbi.nlm.nih.gov/articles/PMC6485617/
  8. American College of Occupational and Environmental Medicine (ACOEM). Multiple chemical sensitivities: idiopathic environmental intolerance (position statement). J Occup Environ Med. 1999;41(11):940-942. https://journals.lww.com/joem/fulltext/1999/11000/multiple_chemical_sensitivities__idiopathic.3.aspx
  9. Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical sensitivities: a systematic review of provocation studies. J Allergy Clin Immunol. 2006;118(6):1257-1264. PMID: 17137865. https://doi.org/10.1016/j.jaci.2006.07.046
  10. Miller CS. Toxicant-induced loss of tolerance—an emerging theory of disease? Environ Health Perspect. 1997;105(Suppl 2):445-453. PMID: 9167978. https://pmc.ncbi.nlm.nih.gov/articles/PMC1469811/
  11. Rincón R, Perales R, Palmer RF, et al. Environmental house calls can reduce symptoms of chemical intolerance: a demonstration of personalized exposure medicine. Prim Health Care Res Dev. 2024;25:e53. PMID: 39434594. https://pmc.ncbi.nlm.nih.gov/articles/PMC11569860/
  12. U.S. Environmental Protection Agency (EPA). Improving Indoor Air Quality. Web page, accessed October 14, 2026. https://www.epa.gov/indoor-air-quality-iaq/improving-indoor-air-quality
  13. U.S. Environmental Protection Agency (EPA). Volatile Organic Compounds’ Impact on Indoor Air Quality. Web page, accessed October 14, 2026. https://www.epa.gov/indoor-air-quality-iaq/volatile-organic-compounds-impact-indoor-air-quality
  14. ISEAI. Clean Indoor Air on a Budget – Helpful Tips for Chronically Ill Patients. June 29, 2023. Web page, accessed October 14, 2026. https://iseai.org/clean-indoor-air-on-a-budget/
  15. U.S. Environmental Protection Agency (EPA). Air Cleaners and Air Filters in the Home. Web page, accessed October 14, 2026. https://www.epa.gov/indoor-air-quality-iaq/air-cleaners-and-air-filters-home
  16. Damiani G, Alessandrini M, Caccamo D, et al. Italian expert consensus on clinical and therapeutic management of multiple chemical sensitivity (MCS). Int J Environ Res Public Health. 2021;18(21):11294. PMID: 34769816. https://pmc.ncbi.nlm.nih.gov/articles/PMC8582949/
  17. Hyvönen S, Poussa T, Lohi J, Tuuminen T. High prevalence of neurological sequelae and multiple chemical sensitivity among occupants of a Finnish police station damaged by dampness microbiota. Arch Environ Occup Health. 2021;76(3):145-151. PMID: 32544007. https://doi.org/10.1080/19338244.2020.1781034
  18. Hurraß J, Heinzow B, Walser-Reichenbach S, et al. AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023. Allergol Select. 2024;8:90-198. PMID: 38756207. https://pmc.ncbi.nlm.nih.gov/articles/PMC11097193/
  19. Lee E, Picard M. Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach. Allergy Asthma Clin Immunol. 2025;21:49. PMID: 41272881. https://pmc.ncbi.nlm.nih.gov/articles/PMC12639879/
  20. International Society for Environmentally Acquired Illness (ISEAI). About EAI – Environmentally Acquired Illness. Web page, accessed October 14, 2026. https://iseai.org/about-eai/
  21. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014;16:7-17. PMID: 23981537. https://doi.org/10.1016/j.mito.2013.08.006
  22. Nathan N. Newsletter #14: Dysfunctional Limbic System. August 29, 2018. Web page, accessed October 14, 2026. https://neilnathanmd.com/newsletter-14-dysfunctional-limbic-system/
  23. Toussaint LL, Whipple MO, Abboud LL, Vincent A, Wahner-Roedler DL. A mind-body technique for symptoms related to fibromyalgia and chronic fatigue. Explore (NY). 2012;8(2):92-98. PMID: 22385563. https://doi.org/10.1016/j.explore.2011.12.003
  24. National Center for Complementary and Integrative Health (NCCIH). “Detoxes” and “Cleanses”: What You Need To Know. Last updated March 2025. Web page, accessed October 14, 2026. https://www.nccih.nih.gov/health/detoxes-and-cleanses-what-you-need-to-know
  25. Busse JW, Reid S, Leznoff A, et al. Managing environmental sensitivity: an overview illustrated with a case report. J Can Chiropr Assoc. 2008;52(2):88-95. https://pmc.ncbi.nlm.nih.gov/articles/PMC2391018/
  26. MedlinePlus. Asthma. Web page, accessed October 14, 2026. https://medlineplus.gov/ency/article/000141.htm
  27. MedlinePlus (U.S. National Library of Medicine). Anaphylaxis. Web page, accessed October 14, 2026. https://medlineplus.gov/ency/article/000844.htm
  28. National Institute of Mental Health (NIMH). Help for Mental Illnesses. Web page, accessed October 14, 2026. https://www.nimh.nih.gov/health/find-help
  29. Agency for Healthcare Research and Quality (AHRQ). Next Steps After Your Diagnosis: Finding Information and Support (patient booklet, PDF). Accessed October 17, 2026. https://www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/diagnosis-treatment/diagnosis/diaginfo/diaginfo.pdf
  30. Association of Occupational and Environmental Clinics (AOEC). Connect with Occupational and Environmental Medicine Clinicians through the AOEC Clinic Directory. Web page, accessed October 17, 2026. https://aoec.org/connect/

Related free guides

Helpful resources

Job Accommodation Network (JAN)

Free guidance on workplace accommodations for multiple chemical sensitivity.

More on the homepage